SOS
WST icon

Silver Oak Securities’s West Pharmaceutical WST Stock Holding History

Silver Oak Securities’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-55
Closed -$20.6K – 545
2023
Q3 		$20.6K Sell
55
-995
-95% -$385K ﹤0.01% 401
2023
Q2 		$402K Sell
1,050
-268
-20% -$95.7K 0.06% 274
2023
Q1 		$458K Buy
+1,318
New +$385K 0.08% 205
2022
Q4 		– Sell
-55
Closed -$20.6K – 493
2022
Q3 		$20.6K Sell
55
-606
-92% -$185K ﹤0.01% 401
2022
Q2 		$207K Sell
661
-39
-6% -$12.7K 0.05% 256
2022
Q1 		$290K Buy
+700
New +$274K 0.06% 240

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Silver Oak Securities's WST Position: Q4 2023 in Review

Silver Oak Securities sold out of West Pharmaceutical (WST) in Q4 2023, closing a stake of 55 shares — an estimated $20.6K sold.

Silver Oak Securities first reported a position in WST in Q1 2022 and held it in 6 quarters. The position peaked at $458K in Q1 2023. 782 funds tracked by Wall St. Rank hold WST as of Q4 2023.

  • Silver Oak Securities reported no remaining West Pharmaceutical position as of Q4 2023 after selling out during the quarter.
  • Silver Oak Securities sold 55 West Pharmaceutical shares in Q4 2023, an estimated $20.6K.
  • Silver Oak Securities first reported a position in West Pharmaceutical in Q1 2022 and held it in 6 quarters.
  • Silver Oak Securities's West Pharmaceutical position peaked at $458K in Q1 2023.
  • 782 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2023.

Based on Silver Oak Securities's 13F filing for Q4 2023, filed 5 Feb 2024.